Study of the Tolerability, Safety, Immunogenicity and Preventive Efficacy of the EpiVacCorona Vaccine for the Prevention of COVID-19

PHASE3

Phase

COMPLETED

Status

3000

Enrollment

OTHER_GOV

Sponsor class

Conditions

BIOLOGICAL: EpiVacCorona (EpiVacCorona vaccine based on peptide antigens for the prevention of COVID-19)
OTHER: Placebo (sodium chloride, a 0.9% solution for the preparation of dosage forms for injections)

Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"